Long‐term safety and sustained efficacy for up to...

  • Main
  • 2020 / 06
  • Long‐term safety and sustained efficacy for up to...

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

Pasi, K. John, Fischer, Kathelijn, Ragni, Margaret, Kulkarni, Roshni, Ozelo, Margareth C., Mahlangu, Johnny, Shapiro, Amy, P’Ng, Stephanie, Chambost, Hervé, Nolan, Beatrice, Bennett, Carolyn, Matsu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Haemophilia
DOI:
10.1111/hae.14036
Date:
June, 2020
File:
PDF, 564 KB
2020
Conversion to is in progress
Conversion to is failed